Chester County News and Community Website
HORSHAM, PA — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has secured approval from Japan’s Ministry of Health, Labor, and Welfare for its XTRAC Momentum™ 1.0 device. This advanced excimer laser, …
STRATA Skin Sciences Gains Approval for Advanced Laser Device in Japan Read More
RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) has announced that China’s National Medical Products Administration (NMPA) has approved its ganaxolone oral suspension. This drug targets epileptic seizures in patients …
Marinus Pharmaceuticals Gains Approval for Seizure Drug in China Read More
PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced positive feedback from the U.S. Food and Drug Administration (FDA) on its proposal to evaluate PBFT02 for treating frontotemporal dementia (FTD) …
Passage Bio Receives FDA Support for Expanding Dementia Treatment Trial Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that its lead DNA medicine candidate, INO-3107, has been granted an Innovation Passport by the U.K.’s Innovative Licensing and Access Pathway (ILAP). …
INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Felanorm, the first generic methimazole oral solution for treating hyperthyroidism in cats. This new medication offers a vital …
FDA Approves First Generic Methimazole Oral Solution for Cats Read More
WASHINGTON, D.C. — The U.S. Department of Labor announced the award of more than $56 million in grants aimed at reducing recidivism and assisting individuals re-entering their communities after incarceration. …
U.S. Department of Labor Awards $56 Million to Aid Reentry for Formerly Incarcerated Individuals Read More
WASHINGTON, D.C. — The U.S. Department of Commerce’s Economic Development Administration (EDA) recently announced a new round of funding totaling approximately $504 million. These implementation grants aim to scale up …
U.S. Commerce Department Awards $504 Million to Boost Tech Hubs Nationwide Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently updated its advisory regarding illnesses linked to Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. As of June 17, 2024, …
FDA Warns Against Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies Amid Illness Outbreak Read More
WASHINGTON, D.C. — This week, in a significant step for the medical world and hope for patients, the U.S. Food and Drug Administration expanded the approval of Elevidys, a gene …
FDA Broadens Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy Patients Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary …
FDA Approves Keytruda Combination for Advanced Endometrial Cancer Read More